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a b s t r a c t
Posttranslational modiﬁcations (PTMs) of cytoskeleton proteins due to oxidative stress associated with
several pathological conditions often lead to alterations in cell function. The current study evaluates the
effect of nitric oxide (DETA-NO)-induced oxidative stress-related S-glutathionylation of cytoskeleton
proteins in human PMNs. By using in vitro and genetic approaches, we showed that S-glutathionylation
of L-plastin (LPL) and β-actin promotes reduced chemotaxis, polarization, bactericidal activity, and
phagocytosis. We identiﬁed Cys-206, Cys-283, and Cys-460 as S-thiolated residues in the β-actin-binding
domain of LPL, where cys-460 had the maximum score. Site-directed mutagenesis of LPL Cys-460 further
conﬁrmed the role in the redox regulation of LPL. S-Thiolation diminished binding as well as the
bundling activity of LPL. The presence of S-thiolated LPL was detected in neutrophils from both diabetic
patients and db/db mice with impaired PMN functions. Thus, enhanced nitroxidative stress may results
in LPL S-glutathionylation leading to impaired chemotaxis, polarization, and bactericidal activity of
human PMNs, providing a mechanistic basis for their impaired functions in diabetes mellitus.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Neutrophils or polymorphonuclear neutrophils (PMNs) are the
most abundant and short-lived white blood cells. They represent the
essential component of the innate immune system and are also
involved in inﬂammatory disorders. PMNs are the ﬁrst cells to reach
the site of infections and their migration is crucial for the resolution
of infections. In consequence defects in PMN chemotaxis result in
severe infections [1,2]. PMNs kill ingested/phagocytosed pathogens
by generating reactive oxygen (ROS) [3] and nitrogen species (RNS)
[4] as well as by nonoxidative mechanisms [5].
Neutrophil adhesion, chemotaxis, bacterial killing, and apoptosis
are modulated by nitric oxide (NO) [6] which along with hydrogen
peroxide may act as intracellular signal transducers [7]. The cellular
redox status is maintained by a delicate balance between ROS and RNS
(RONS) production and their effective scavenging by cellular enzy-
matic and nonenzymatic antioxidants [8,9]. A perturbation in this
balance is thus detrimental for cellular homeostasis. Activated human
PMNs are a major source of ROS generation [10] and also synthesize
NO [11]. Several research groups, including ours, have shown the
involvement of NADPH oxidase (NOX-2) in NO-mediated augmenta-
tion of PMN free radical generation [12–14].
Increased oxidative stress is also of critical importance in many
pathological conditions and is often associated with defective neu-
trophil chemotaxis and enhanced propensity to infection [15,16].
Impaired PMN chemotaxis, bactericidal activity, and oxidative stress
are a hallmark of diabetes mellitus (DM), a devastating metabolic
disorder [17,18] and therefore it is important to understand the
molecular mechanisms underlying defective PMN functions. S-
Glutathionylation (S-thiolation), a redox-mediated posttranslational
modiﬁcation of cysteine residues described in a substantial number of
proteins, plays an important role in the cellular adaptation to
oxidative stress [19,20]. Cysteines surrounded by basic residues have
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the highest susceptibility for S-thiolation [21,22]. S-Glutathionylation
takes place via thiol–disulﬁde exchange with oxidized glutathione,
by reaction of oxidant-induced protein thiyl radicals with reduced
glutathione, or by reaction of a nitrosothiol with another thiol [23,24].
NO-induced oxidative stress also causes glutathionylation of several
proteins. Although NO induces protein S-nitrosylation, several studies
suggest that NO/GSH may cause conversion of S-nitrosylation into the
more stable modiﬁcation, S-glutathionylation [25,26]. Proteins, which
are normally not glutathionylated, also undergo this modiﬁcation,
leading to altered protein function in pathological conditions [27,28]
such as atherosclerosis, cancer, neurodegenerative diseases, and dia-
betes [29–31].
L-Plastin (LPL), an important β-actin-bundling protein, has
many cysteine residues and is exclusively present in leukocytes
[32]. LPL phosphorylation results in its enhanced afﬁnity for β-
actin [33] and modulates PMN migration, maintenance of lamelli-
podia, ﬁlopodia, and integrin function [34]. On the contrary LPL-
deﬁcient PMNs are unable to kill bacterial pathogens and even lose
their capability of generating an adhesion-dependent respiratory
burst [35]. Recently, Sakai et al. reported that fMLP-mediated ROS
production induced β-actin S-glutathionylation in human PMNs
[36]; of note, S-glutathionylation of the actin interacting proteins
is yet to be demonstrated.
The current study was undertaken to assess the molecular
mechanisms involved in impaired PMN functions following high
oxidative stress. Human PMN chemotaxis, polarization, phagocy-
tosis, and bactericidal activity were investigated under conditions
of high oxidative stress both in vitro (treatment with NO donor,
DETA-NO) and ex vivo (PMNs from diabetic subjects and db/db
mice). Our results highlight the role of S-glutathionylation of L-
plastin and β-actin in impaired neutrophil migration, polarization,
and bacterial killing.
Materials and methods
Materials
Percoll was from Amersham Biosciences Corp. (Uppsala, Sweden),
antibodies against L-plastin, β-actin, GFP, and LPL siRNA were from
Santa Cruz Biotechnology (Santa Cruz, USA), and anti-glutathione
monoclonal antibody was purchased from Virogen (Watertown, MA).
The phospho-Ser Ab against L-plastin was a kind gift from Dr. Eric
Brown, University of California (Genentech, South San Francisco,
USA). Biotinylated GSH monoethyl ester (BioGEE) was from Mole-
cular Probes, β-G-actin was from Cytoskeleton (Boechout, Belgium),
and puriﬁed human L-plastin protein was obtained from Origene
Technologies Inc. (Rockville). mEmerald-Plastin-N-10 was a gift from
Michael Davidson (Addgene plasmid No. 54233). Lipofectamine LTX
and Plus reagent were obtained from Invitrogen (Carlsbad, CA).
Recombinant human GM-CSF was purchased from Peprotech (Rocky
Hill, USA), VAS-2870 was from EMD Millipore (Billerica, USA), and all
the primers used in the study were obtained from Integrated DNA
Technology (India). DETA NONOate (DETA-NO), N-ethylmaleimide
(NEM), N-Formyl-Met-Leu-Phe (fMLP), dithiothreitol (DTT), and all
other chemicals used in the study were purchased from Sigma
Aldrich Co. (St. Louis, MO, USA).
Isolation of PMNs from human blood and mice bone marrow
Neutrophils were isolated from the blood of the healthy volunteers
and diabetic patients as described previously [4]. Diabetic patients
were recruited based on the criteria of the American Diabetes
Association. A total of 17 patients were included in the study (10
females, 7 men, age 21–55), fasting glucose was 156mg/dl and HbA1c
Z 9%. Sex-matched and age-matched healthy volunteers were
selected for the comparison. C57BL/6 control and the age-matched
db/db mice (leptin receptor knockout), iNOS knockout mice (iNOS–/–),
and p47phox knockout mice (p47–/–/neutrophil cytosolic factor 1 null
mice, NCF1–/–) were procured from The Jackson Laboratory (Bar
Harbor, ME, USA). 12 to 16-week-old mice were used in all the
experiments. Purity of the isolated human neutrophils and of the
mouse bone marrow neutrophils was assessed by using CD15 and
Ly6G labeling, respectively, using ﬂow cytometry (FACS Calibur, BD,
USA). Purity of the isolated neutrophils was always more than 90%
with 495% viability as conﬁrmed by trypan blue. The study protocol
for human blood samples was approved by ethical committees of
KGMU and CSIR-CDRI, Lucknow, India. Studies with C57BL/6 wild-
type, diabetic mice (db/db), iNOS knockout mice (iNOS–/–), and p47phox
knockout mice (NCF1–/–) were performed according to the Institu-
tional Animal Ethics Committee of CSIR-CDRI, India.
ROS generation
PMNs (1  106 cells/ml) loaded with 2,7-dichloroﬂuorescein
diacetate (DCF-DA, 10 mM) for 10min were subsequently treated with
DETA-NO (300 mM) for 15 and 30min at 37 1C. Ten thousand events
were acquired using FACS Calibur (Becton Dickinson, USA) and subse-
quently ROS generation was assessed using the Cell Quest program.
In the current study, cells were treated with the NO donor for
15 or 30 min (as noted in the subsequent sections), centrifuged,
and resuspended to assess the effects on fMLP-induced chemo-
taxis and polarization, or incubated with bacteria to evaluate the
effect on phagocytosis and ROS generation.
F-actin content
PMNs (1  106 cells/ml) were stimulated with DETA-NO (300 mM)
at 37 1C for 15 and 30min. After stimulation, cells were ﬁxed with 4%
PFA for 30 min at room temperature and then permeabilized with 0.1%
Triton X-100. The cells were incubated with phalloidin–TRITC
(0.25 mM) for 45 min at room temperature and were subsequently
stained with DAPI (1 μg/ml). Specimens were mounted in Antifade
and images were acquired using a Carl Zeiss confocal microscope
(Oberkochen, Germany) equipped with DPSS-561 laser source using a
63x oil objective lens. Images were further processed using the Adobe
Photoshop software. Quantitative assessment was made after the
extraction of Phalloidin–TRITC with methanol overnight, and ﬂuores-
cence was measured using a BMG LABTECH POLARstar omega
microplate reader (Ortenberg, Germany) [36]. F-actin content was also
measured after labeling the cells with phalloidin–FITC, and was
analyzed by a ﬂow cytometer (FACS Calibur, BD USA).
Immunoﬂuorescence
Human PMNs after stimulation with DETA-NO (300 mM) for
15 min at room temperature were assessed for S-glutathionylation
by following the method of Sakai et al. [36]. Cells were incubated
with GSH (1:500) and L-plastin (1:500) antibodies overnight at
4 1C, followed by staining with secondary antibodies (1:500) for
1 h at room temperature, and nuclei were stained with DAPI (1 μg/
ml). After mounting, images were acquired using a Carl Zeiss
confocal microscope (Oberkochen, Germany) equipped with DPSS-
561 laser source using a 63x oil objective lens.
Phagocytosis assay
The phagocytosis assay was performed as described previously
[4]. FITC-coated bacteria were added to the PMN (1:50) suspension
containing 1 mM calcium and 1 mM magnesium chloride to assess
phagocytosis at 37 1C for 15 min. Samples were acquired using
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FACS Calibur at 488-nm excitation. Trypan blue (200 mg/ml) was
added to quench the ﬂuorescence of adherent bacteria.
Neutrophil polarization and migration assay
For the neutrophil polarization assay, control and DETA-NO-
treated (300 mM for 15 min) human PMNs (40,000 cells in HBSS
[containing 10 mM glucose, 1 mM calcium, and 1 mM magnesium
chloride]) were seeded on poly-L-lysine-coated coverslips. For DTT
treatment, cells were treated with DETA-NO followed by incuba-
tion with DTT (1 mM) for 10 min at 37 1C and then DTT was
removed by washing the cells with HBSS. PMNs were stimulated
with 10 mM fMLP for 10 min in a CO2 incubator. After stimulation,
the cells were ﬁxed with 4% PFA and permeablized with 0.1%
Triton X-100. The cells were then stained with phalloidin–TRITC
(0.25 mM) for 1 h at room temperature. Nuclei were stained with
DAPI (1 μg/ml). After mounting, images were acquired using a TCS
SP8 Leica confocal microscope (Oberkochen, Germany) equipped
with a DPSS-561 laser source using a 63x oil objective lens.
Migration of control and DETA-NO-treated (300 mM for 15 min)
cells was measured in the Neuro Probe 48-well microchemotaxis
chamber. The lower wells were ﬁlled with the chemoattractant
(100 nM fMLP) and kept at 37 1C for 10 min. The ﬁlter membrane
(5 mm pores) was placed over the bottom wells. After the silicone
gasket was applied, the upper wells were ﬁlled with 18,000 cells/
well (in HBSS containing 10 mM glucose, 1 mM calcium, and 1 mM
magnesium chloride). The ﬁlled chamber was incubated at 37 1C in
humidiﬁed air with 5% CO2 for 2 h. The transwell membrane was
then removed, and the number of cells migrated was quantitated
by staining the membrane with DAPI (1 μg/ml) visualized under a
Leica ﬂuorescence microscope.
Bactericidal assay
Control and DETA-NO-treated (300 mM for 15 and 30 min)
PMNs were incubated with Escherichia coli (containing pCMV6-
entry vector) for 30 min. After incubation, the cells were washed
twice with HBSS to remove nonphagocytosed bacteria. The cells
were lysed with sterilized water and the lysates (100 ml) were
seeded on LB agar plates containing kanamycin (25 mg/ml) and
incubated overnight at 37 1C. Live bacteria were counted and
expressed as the number of colony-forming units (CFU). The
bactericidal assay was also performed in PMNs following silencing
with LPL siRNA.
LPL silencing in human PMNs
LPL silencing was performed using the Nucleofactor II electro-
poration device (Amaxa Biosystems, Cologne, Germany) and the
Nucleofector program T-019. After transfection, the cells were
cultured in RPMI containing 10% FBS and 100 ng/ml GM-CSF to
prevent PMN apoptosis. Viability of the PMNs was assessed 24 h
after transfection by propidium Iodide (PI) staining and found to
be Z80%.
Detection of S-glutathionylation with BioGEE
One vial of BioGEE (Stock 1.78 mM, ﬁnal concn: 296 μM) was
suspended in 100 μl of HBSS (containing 10 mM glucose, 1 mM
calcium, and 1 mM magnesium chloride), kept for 30 min at 37 1C,
and then added to 1  107 cells/ml. The cells were incubated at 37 1C
and after 30 min cells were pelleted and washed once with HBSS
followed by stimulation with DETA NO (300 mM for 30 min) at 37 1C.
Cells were lysed with buffer containing 0.1 mM EDTA, 0.1 mM EGTA,
1 mM sodium orthovanadate, 1 mM sodium ﬂuoride, protease inhi-
bitor cocktail, 5 mM diisopropylﬂuorophosphate (DFP), 0.5% NP-40,
and 100 mM NEM. Proteins were pulled down with neutravidin
beads and samples were run on nonreducing SDS-PAGE and subse-
quently probed with Strep-HRP.
Immunoprecipitation (IP) and Western blotting
Human PMNs (total protein, 500 mg) were lysed with ice-cold
lysis buffer at 4 1C for 30 min. The supernatant was precleared
with protein A/G agarose (Amersham Biosciences, Upsala, Sweden)
and incubated with 1 μg of β-actin or L-plastin antibody overnight
at 4 1C. Subsequently, 20 μl of protein A/G agarose was added and
incubated for 3 h at room temperature. The beads were washed,
resuspended in gel loading buffer, denatured at 95 1C for 10 min,
and subsequently analyzed by Western blotting.
Proteomic identiﬁcation
The BioGEE-labeled and NO-stimulated PMNs were suspended
in ice-cold lysis buffer and subjected to the pulldown assay using
nutravidin agarose beads. After heat denaturation, an equal
amount of protein was loaded and subjected to 10% SDS-PAGE
followed by Coomassie staining. The Coomassie-stained bands of
different molecular weights were excised from the gel and sub-
jected to mass spectrometry by MALDI-TOF through a commercial
source (Sandor Proteomics, Hyderabad).
Iodoacetamide (IAM) switch to label cysteine residues
Human PMNs (1  106 cells/ml) were treated with DETA-NO
(300 mM) for 30 min. After treatment, the cells were lysed with lysis
buffer (containing 150 mM NaCl, 50 mM Tris, 0.1 mM EDTA, 0.1 mM
EGTA, 5 mM DFP, protease inhibitor cocktail, and 100 mM NEM).
Excess NEM was removed by passing the cell lysates through a
Sephadex desalting column. Cell lysates were reduced with 1 mM
TCEP at 56 1C for half an hour. After reduction, the lysates were
incubated with 50 mM IAM for 45 min in the dark at room tempera-
ture. The proteins were separated on SDS-PAGE and stained with
Coomassie. The Coomassie-stained protein band corresponding to LPL
was excised and processed for in-gel digestion at the NCBS C-CAMP
proteomics facility using the protocol of Shevchenko et al. [37]. Full
mass spectrometry in a mass range between m/z 300 and m/z 2000
was performed in an Orbitrap mass analyzer with a resolution of
30,000 atm/z 400 and an AGC target of 2  105. The strongest signals
were selected for collision-induced dissociation (CID)–MS/MS in the
LTQ ion trap.
For LC-LTQ Orbitrap MS analysis, samples were resolubilized in 2%
[v/v] acetonitrile, 0.1% [v/v] formic acid in water and injected onto an
Agilent 1200 (Agilent, Santa Clara, CA, USA) nanoﬂow LC system that
was in-line coupled to the nanoelectrospray source of a LTQ-Orbitrap
discovery hybrid mass spectrometer (Thermo Scientiﬁc, San Jose, CA,
USA). Peptides were separated on Zorbax 300SB-C18 (Agilent, Santa
Clara, CA, USA) by a gradient developed from 2% [v/v] acetonitrile, 0.1%
[v/v] formic acid to 80% [v/v] acetonitrile, 0.1% [v/v] formic acid in
water over 70 min at a ﬂow rate of 300 nl/min. Full MS in a mass
range between m/z 300 and m/z 2000 was performed in an Orbitrap
mass analyzer with a resolution of 30,000 at m/z 400 and an AGC
target of 2  105. The strongest ﬁve signals were selected for CID–MS/
MS in the LTQ ion trap at a normalized collision energy of 35% using
an AGC target of 1  105 and twomicroscans. Dynamic exclusionwas
enabled with one repeat counts during 45 s and an exclusion period of
180 s. Peptide identiﬁcation was performed by CID-based MS/MS of
the selected precursors, which also revealed the site of cysteine
modiﬁcation. For protein/peptide identiﬁcation, MS/MS data were
searched against the Uniprot/Swissprot amino acid sequence database
(downloaded in August 2013) using an in-house Mascot server
(version 2.4) through the Proteome Discoverer 1.4 software. The
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search was set up for full tryptic peptides with a maximum of three
missed cleavage sites. NEM, carbamidomethyl on cysteine, and
oxidized methionine were included as variable modiﬁcations. The pre-
cursor mass tolerance threshold was 10 ppm, and the maximum
fragment mass error was 0.8 Da. The signiﬁcance threshold of the ion
score was calculated based on a false discovery rate of o1%, estimated
by the peptide validator node of the Proteome Discoverer software.
Site-directed mutagenesis of LPL
Site-directed mutagenesis of LPL cys460 - Ser460 was performed
using a QuickChange site-directed mutagenesis kit (Strategene, Santa
Clara, USA). The mutated plasmid was generated following the
manufacture's instruction. Mutation was conﬁrmed by DNA sequen-
cing. HEK293T cells were cultured in DMEM medium with 10% FBS
and 100 mg/ml penicillin/streptomycin. Cells were transfected with
2.5 mg of wild-type and mutated LPL clone using LTX-plus liposomal
transfection reagent. After 24 h of transfection, cells were treated with
diamide (0.5 mM) for 30min followed by lysis with lysis buffer
containing 100 mM NEM. For invasion assay, cells were trypsinized
and seeded on polycarbonate membranes. LPL expression was mon-
itored byWestern blotting with anti-GFP antibody and ﬂow cytometry.
Cell invasion assay
Cell invasion assay was performed using Boyden chamber.
Polycarbonate ﬁlters (8 mm pores) were coated with Matrigel on
the upper surface and ﬁbronectin (10 mg/ml) on the lower surface.
HEK293T (20,000) cells were seeded and incubated for 24 h. Then
the ﬁlters were ﬁxed with 4% PFA and stained with DAPI (1 mg/ml).
Invaded cells on the lower surface were counted under a ﬂuor-
escent microscope.
Real-time PCR
Total RNA was isolated from human PMNs with the help of Tri
reagent, and cDNA was synthesized using the RevertAid H Minus
ﬁrst-strand cDNA synthesis kit (Fermentas Life Science, Vilnius,
Lithuania) using the oligo(dT) primer. Grx 1 mRNA was quantiﬁed
by real-time PCR using the primer sequence Grx1F 50-AGCCACCAAC-
CACACTAACG-30 and Grx1R 50-CTGCCACTCACCTGTGGTTAC-30 using
the Light Cycler instrument (Roche Applied Science, Lewes, UK) with
the 2 Maxima SYBR Green RT-PCR Master Mix (Roche Applied
Science, Lewes, UK). β-Actin was used as the normalization control.
In vitro S-glutathionylation of LPL
To induce S-glutathionylation, LPL (1 mM) was incubated with
oxidized glutathione (GSSG 2 mM) for 30 min at room tempera-
ture. After incubation, the samples were boiled in Laemmli sample
buffer (without DTT) for 5 min, separated on SDS-PAGE, and
probed with the anti-GSH antibody
In vitro actin binding and bundling assay
The effect of LPL S-glutathionylation on β-actin binding and
bundling was investigated as described by Janji et al. with some
modiﬁcations [33]. Recombinant human LPL (1 mM) was S-
glutathionylated in vitro with GSSG (2 mM) and excess of GSSG was
removed using a desalting column. Human G-actin (6 mM) was
polymerized overnight at 4 1C in the presence of LPL or LPL-SSG in
actin polymerization buffer containing 100 mM KCl, 1 mM MgCl2,
1 mM ATP, 0.5 mM EGTA, 50 mM sodium phosphate buffer, pH 7.0.
Actin and LPL were separated by ultracentrifugation at 200,000g for
30 min. For the bundling assay, G-actin was polymerized overnight
and centrifuged at 12,000g for 15 min for separation of spontaneously
formed β-actin bundles, and then incubated with LPL or LPL-SSG for
1 h. LPL-induced β-actin bundles were sedimented by centrifugation
at 12,000g for 15 min.
Statistical analysis
Data in the manuscript have been reported as mean 7 SEM
from at least 3–5 independent experiments. The data were
analyzed by one-way ANOVA followed by Newman-Keul's post
hoc analysis. Comparisons between the control and the treated
samples were performed using Student's t test. A P value of o0.05
was considered to indicate statistical signiﬁcance.
Results
Effect of NO on PMN chemotaxis and polarization
Nitric oxide is elevated in various inﬂammatory disorders and
diseases, so we ﬁrst investigated the possible role of human
neutrophil migration, a crucial event common to these conditions.
To that end we used fMLP (100 nM) as a chemoattractant to induce
human neutrophil migration, as previously described [38]. Neutro-
phil chemotaxis in NO-pretreated cells was signiﬁcantly decreased in
the experimental cells as compared to vehicle-treated cells in a
concentration-dependent manner with the most signiﬁcant diminu-
tion observed at 100 and 300 mM concentration of DETA-NO
(Fig. S1A). Thus, for the subsequent experiments only one concentra-
tion of DETA-NO (300 mM) was used. NO-induced inhibition of
human PMN migration was reversed by treatment with DTT
(Fig. 1A, B), suggesting redox regulation of the process. Neutrophil
polarization is critical for the chemoattractant-induced PMN migra-
tion and is characterized by a change in the shape of the neutrophils,
from round to polarized. The NO-treated human PMNs exhibited
reduced formation of pseudopods as compared to the control cells
when stimulated with fMLP (Fig. 1C, D), conﬁrming the previous
reports of defective polarity and migration in NO-pretreated cells
[39]. Moreover, enhanced migration of bone marrow neutrophils
from iNOS–/– mice conﬁrmed the previously deﬁned role of intracel-
lular NO in neutrophil migration (Fig. 1E, F).
NO acts in a cGMP-dependent and independent manner; there-
fore, cGMP- involvement was assessed by using ODQ, a guanylate
cyclase inhibitor. Pretreatment of human PMNs with ODQ (10 mM)
did not affect NO-induced decrease in chemotaxis, indicating that a
cGMP-independent pathway was responsible for the effect (Fig. S1B).
Phagocytosis and bacterial killing in NO-treated PMNs
The effect of exogenous NO on phagocytosis and bactericidal
activity was examined in human PMNs. Phagocytosis was signiﬁ-
cantly decreased at 30 min in NO-pretreated cells as compared to
control PMNs and this inhibition was also reversed by DTT
(Fig. 2A). NO treatment also reduced bactericidal activity. In
untreated PMNs, the number of bacteria was signiﬁcantly reduced,
but a greater number of CFU were detected in the NO-pretreated
cells, an effect reversed by DTT (Fig. 2B, C).
Effect of NO on protein S-glutathionylation
Previous studies from our group have shown that NO augmented
ROS generation in human PMNs [13,40]. ROS generation was
measured using DCF-DA. PMNs treated with DETA-NO showed
signiﬁcant enhancement of ROS generation at 15 and 30 min
(Fig. 3A). Involvement of NADPH oxidase in NO-induced free radical
generation has been documented by this lab [13,41]. Consistent with
our previous observations, involvement of NOX-2 was further
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conﬁrmed by using PMNs from NCF1–/– mice where NO-induced free
radical generation was signiﬁcantly reduced (Fig. 3B). During phago-
cytosis, PMNs generate ROS/RNS to kill the internalized pathogens.
Therefore we next examined phagocytosis-induced ROS generation
in NO-pretreated PMNs. There was signiﬁcant inhibition in ROS
generation after bacterial phagocytosis in NO-pretreated cells as
compared to untreated cells (Fig. 3C).
Since oxidative stress may cause reversible or irreversible S-
glutathionylation of proteins, we measured it in neutrophils
pretreated with DETA-NO for 15 min. Protein S-glutathionylation
was detected using a monoclonal anti-GSH antibody and NEM
treatment, which alkylates thiol groups and reduced the signal,
conﬁrming the speciﬁcity of the anti-GSH antibody binding
(Fig. 3D). NO-induced S-glutathionylation was also signiﬁcantly
decreased in PMNs from NCF1–/– mice, supporting the involve-
ment of NADPH oxidase in ROS formation in NO-induced S-glu-
tathionylation (Fig. 3E)
To further conﬁrm the presence of NO-induced S-glutathiony-
lation, we used another experimental approach where PMNs were
loaded with BioGEE and then treated with NO. As shown in Fig. 3F,
an increase in the amount of proteins undergoing glutathionyla-
tion was observed. Treatment with DPI (a NOX and NOS inhibitor),
VAS-2870 (a NOX inhibitor), and cPTIO (an NO scavenger) reduced
the amount of BioGEE-labeled proteins (Fig. S1C). To identify the
speciﬁc proteins modiﬁed by S-glutathionylation, immunoprecipi-
tates from NO-pretreated PMNs were separated by SDS-PAGE.
After Coomassie staining, S-glutathionylated proteins were identi-
ﬁed by MALDI-TOF. Among others two important cytoskeleton
proteins L-Plastin (LPL) or lymphocyte cytosolic protein (LCP1) and
β-actin were identiﬁed. Since LPL glutathionylation occurred prior
to β-actin and little is known about it, we further explored in
detail the potential signiﬁcance of this phenomenon.
Lysates of BioGEE-labeled and DETA-NO-stimulated cells were
precipitated with neutravidin beads and probed with the anti-LPL
Fig. 1. NO induced inhibition of neutrophil chemotaxis and polarization. (A) fMLP (100 nM) induced neutrophil migration in human PMNs (1  106 cells/ml) pretreated with
DETA-NO (300 mM) for 15 and 30 min as shown by labeling with DAPI (1 mg/ml). Treatment with DTT (1 mM for 10 min) reversed the effect. Scale bars: 50 mm in the images.
(B) Bar diagram represents mean 7 SEM (n¼5). (C) Cells (1 106 cells/ml) of control human PMNs treated with fMLP (10 mM) alone for 15 min or DETA-NO (300 mM) for 15
min followed by stimulation with fMLP for 10 min. (D) The bars in the right panel represent the percentage of cells with pseudopods. Scale bars: 50 mM in the images. Δ
represents lamellipodium and * represents uropod in the image. (E) fMLP (100 nM) induced migration in wild-type and iNOS–/– mice neutrophils. Scale bars: 100 mM in the
images. (F) Bar diagram represents mean 7 SEM (n¼3). Data represent mean 7 SEM of ﬁve independent experiments. *Po0.05, **Po0.01 (Student's t test), ***Po0.001 vs
control neutrophils, @@Po0.01 vs neutrophils treated with NO for 15 min, $$$Po0.001 vs fMLP-treated control neutrophils.
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Fig. 2. Effect of NO on phagocytosis and bactericidal activity of human PMNs. (A) Phagocytosis of FITC-labeled bacteria in human PMNs following treatment with DETA-NO
(300 mM). Human PMNs (1  106 cells/ml) were treated with DETA-NO (300 mM) for 15 and 30 min followed by incubation with FITC-labeled bacteria (1:50). (B) Bar diagram
represents CFU of E. coli in control and NO-treated (300 mM) PMNs (1  106 cells/ml). (C) Images of representative culture plates. Treatment with DTT (1 mM) leads to
reversal of NO-induced inhibition. Data represent mean 7 SEM of ﬁve independent experiments. ***Po0.001 vs control neutrophils, $Po0.05 vs control neutrophils with
bacteria, #Po0.05 vs NO-treated (30 min) cells with bacteria, @@@Po0.001 vs neutrophils treated with NO for 15 min.
Fig. 3. NO induced oxidative stress. (A) Nitric oxide induced ROS generation in PMNs from healthy control neutrophils. PMNs (1  106 cells/ml) were incubated with DCF-
DA for 10 min followed by stimulation with DETA-NO (300 mM) for 15 and 30 min. (B) Comparison of NO-induced ROS generation in wild-type and NCF1–/– mice. (C) ROS
generation in control and NO-treated cells after phagocytosis of bacteria. (D) Detection of S-glutathionylation using the anti-GSH antibody. PMNs were stimulated with
DETA-NO (300 mM) followed by lysis with NEM (100 mM)-containing lysis buffer. S-Glutathionylated proteins were detected by Western blotting using the anti-GSH
monoclonal antibody. Pretreatment with NEM (100 mM) for 15 min reduced the S-glutathionylation signal. (E) NO-induced S-glutathionylation in wild-type and NCF1–/–
mice. (F) Human PMNs (1  107 cells/ml) were incubated with BioGEE (300 mM) for 30 min and then treated with DETA-NO (300 mM) for 30 min. BioGEE-labeled proteins
were probed with Strep–HRP. Data represent mean 7 SEM of ﬁve independent experiments. *Po0.05, **Po0.01, ***Po0.001 vs control neutrophils, @Po0.05 (Student's t
test) vs control neutrophils treated with NO for 15 min, $$$Po0.001 vs control neutrophils with bacteria.
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and anti-β-actin antibodies. As shown in Fig. 4A and B, NO-
induced glutathionylation of LPL and β-actin was clearly detected.
S-Thiolation of LPL and β-actin was further conﬁrmed by immu-
noprecipitation using LPL and β-actin antibodies and by probing
with the anti-GSH antibody (Fig. 4C, D). We also conﬁrmed LPL S-
glutathionylation by immunostaining of PMNs (Fig. 4E). Pulldown
with the anti-LPL antibodies from BioGEE-labeled lysates and
probing with streptavidin–HRP also demonstrated that in NO-
treated PMNs, LPL undergoes S-glutathionylation (Fig. S1D). Since
NO or related species can lead to S-nitrosylation and tyrosine
nitration, we checked these possibilities by using anti-SNO and
anti-nitrotyrosine antibodies in Western blotting. However, no
such posttranslational modiﬁcations were detected (Fig. S1E). Our
next objective was to identify the susceptible cysteine residues of
LPL undergoing glutathionylation. We performed redox switch
using IAM to label oxidized cysteines residues. LC–MS/MS data
from IAM switch mapped potential LPL S-glutathionylation sites:
Cys-206, Cys-283, and Cys-460. Control sample was used to check
Fig. 4. NO-induced S-glutathionylation of LPL and β-actin. BioGEE-labeled proteins were captured with neutravidin beads and probed with the anti-LPL (A) and anti-β-actin
(B) antibodies. L-plastin (C) and β-actin (D) were immunoprecipitated from the DETA-NO (300 mM for 15 and 30 min)-treated neutrophil lysate and probed with the anti-GSH
antibody. Treatment with DTT (10 mM) leads to reduction of LPL glutathionylation. (E) Glutathionylation immunostaining of control and DETA-NO (300 mM)-treated PMNs (1
 106 cells/ml). Fixed PMNs after permeabilization were incubated with anti-GSH (1:500) and anti-LPL (1:500) antibodies overnight at 4 1C followed by incubation with the
Alexa Fluor 488 anti-mouse and 647 anti-rabbit antibodies (1:500) for 1 h at room temperature. The nuclei were stained with DAPI (1 mg/ml). Data are shown as the mean 7
SEM of ﬁve independent experiments. *Po0.05, **Po0.01, ***Po0.001 vs control neutrophils, $$$Po0.001 vs neutrophils treated with NO for 15 min.
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effective blocking by NEM, where TCEP was not used. In this
sample only NEM-modiﬁed peptides were observed. NEM-
modiﬁed spectras for Cys 206, 283, and 460 are shown in
Figs. S2A–C. Representative MS/MS spectra of IAM-modiﬁed Cys-
206, Cys-283, and Cys-460 are shown in Fig. 5A, C, and D. All these
residues were localized in the β-actin-binding domain of LPL
(Fig. 5B). Among these residues Cys-460 was found in most of
the samples and with the maximum protein score.
In vitro S-glutathionylation of LPL and interaction with β-actin
To further assess LPL glutathionylation, puriﬁed recombinant
human LPL protein was treated in vitro with oxidized glutathione
(GSSG). As shown in Fig. 5E GSSG (2 mM) induced S-glutathionylation
of human LPL, which was reversed by treatment with DTT (10 mM for
10 min). To explore the potential relevance of this observation, the
effects of LPL S-thiolation on β-actin bundling and on the interaction
of LPL with β-actin were investigated. LPL S-glutathionylation reduced
β-actin binding as well as bundling activity of LPL in vitro (Fig. 5F, G).
Mutagenesis of LPL cysteine460 to serine460 residue
To further conﬁrm the role of the LPL cysteine residues in the
redox regulation, we replaced a serine residue at highly glutathiony-
lated site cysteine 460 using site-directed mutagenesis. Among the
identiﬁed cysteine residues Cys-460, Cys-283, and Cys-206, Cys-460
had a maximum score; therefore we mutated this cysteine residue.
Mutation was conﬁrmed by DNA sequencing (Fig. S2D). Control and
mutant LPL clones were overexpressed in HEK293T cells, because LPL
is not expressed in these cells. Expression of wild-type and mutated
LPL was similar as conﬁrmed byWestern blotting and ﬂow cytometry
(Fig. 6A, B). S-Glutathionylation was induced in HEK293T cells by
treatment with diamide (0.5 mM) for 30 min. Wild-type LPL was S-
glutathionylated by treatment with diamide while mutated LPL was
resistant to diamide-induced glutathionylation (Fig. 6C). Since LPL
expression induced invasive properties in HEK293T cells [33], an
invasion assay was performed. Whereas expression of wild-type as
well as mutated LPL conferred invasive properties in HEK293T cells,
diamide pretreatment augmented invasion in wild-type transfected
Fig. 5. IAM labeling of control neutrophils. Representative MS/MS spectra of IAM-labeled peptide. LPL protein was identiﬁed by 24 different peptides, 3 of which were found
to be carbamidomethylated at cysteine residues. Representative spectra of the modiﬁed peptide at Cys206, Cys283, and Cys460 are shown (A, C, and D). (B) Sequence of human
LPL protein. Red indicates sequence present in the CH domain (domain 1, 121–236, 265–375, and domain 2, 398–501, 518–624), blue indicates cysteine identiﬁed by IAM
labeling. (E) In vitro S-glutathionylation of L-plastin. In vitro treatment with oxidized glutathione (2 mM) for 30 min at room temperature caused S-glutathionylation of
puriﬁed human LPL protein (1 mM). (F) In vitro S-glutathionylation reduced the bundling activity of LPL. After removal of spontaneously formed actin bundles, actin (6 mM)
was incubated with S-glutathionylated or non-S-glutathionylated LPL for 1 h. Then, actin bundles were sedimented by centrifugation at 12,000g for 15 min. (G) Effect of
in vitro S-glutathionylation of LPL on its interaction with β-actin. G actin (6 mM) was copolymerized overnight with S-glutathionylated or non-S-glutathionylated LPL followed
by ultracentrifugation at 200,000g for 30 min. The pellets were resolved by SDS-PAGE and stained with Coomassie. Densitometry analysis of the gel shows % actin in the
bundling assay (F) and % LPL in the actin binding assay (G). Blot and gel images are representative of three different experiments. *Po0.05 (Student's t test), ***Po0.001 vs
LPL without GSSG, $$Po0.01 vs GSSG treated LPL.
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cells but not in mutated LPL overexpressed cells (Fig. 6D), which
further conﬁrmed the signiﬁcance of Cys-460 glutathionylation in the
regulation of LPL functions. Cell–cell contact formation was also red-
uced in wild-type and mutated LPL overexpressed cells as conﬁrmed
by their culture in suspension (data not shown).
Effect of NO-induced S-glutathionylation on the F-actin content
Since β-actin S-glutathionylation inhibits its polymerization and F-
actin formation, we next investigated whether NO-induced oxidative
stress also affects β-actin polymerization. Neutrophils treated with
DETA-NO showed a signiﬁcantly less amount of F-actin as compared
to the control resting cells (Fig. 7A, B). Fluorescence of phalloidin–
TRITC was also measured after methanol extraction, conﬁrming the
previous results (Fig. 7C). Changes in phalloidin–FITC/TRITC ﬂuores-
cence were also consistent with a decline in NO-treated PMNs
(Fig. 7D, E).
Effect of LPL silencing in human PMNs
To check the functional involvement of LPL in human PMNs a
loss of function strategy by means of siRNA silencing was
employed. We observed signiﬁcant reduction of neutrophil migra-
tion in LPL-deﬁcient PMNs (Fig. 8A, B). Consistently, when infected
with E. coli, bacterial killing was markedly reduced in LPL-deﬁcient
PMNs as compared to control PMNs (Fig. 8C). To assess the role of
LPL in NO-induced actin S-glutathionylation, actin glutathionyla-
tion and F-actin formation were assessed after NO treatment in
control and LPL-silenced PMNs. NO-induced decrement in F-actin
formation (Fig. 8D) and enhancement of actin glutathionylation
(Fig. 8E) were not signiﬁcantly affected in LPL-silenced PMNs,
which suggest that NO-induced actin glutathionylation is inde-
pendent of LPL. Phagocytosis was also not signiﬁcantly affected in
LPL-silenced PMNs (Fig. S2E). LPL expression in LPL siRNA-treated
cells was signiﬁcantly reduced (Fig. 8F).
Functional response of PMNs and LPL S-glutathionylation in diabetic
subjects
Next we assessed LPL S-glutathionylation in pathological condi-
tions. Since diabetes mellitus is associated with enhanced oxidative
stress and impaired PMN responses, we hypothesized that defective
PMN function in diabetes might be associated with enhanced S-
glutathionylation of LPL in diabetic subjects. To test this hypothesis,
LPL S-glutathionylation and various functional responses in PMNs
from diabetic patients were compared with those of neutrophils
from control subjects. Enhanced LPL S-glutathionylation was
observed in PMNs of diabetic patients, which was reduced after
treatment with DTT (Fig. 9A). Basal ROS generation was also
enhanced in diabetic patients' neutrophils (Fig. 9B). Glutaredoxin is
a thiol disulﬁde oxido-reductase, which catalyzes both the formation
and the reduction of mixed disulﬁdes between protein thiols. Grx-1
mRNA expression in neutrophils was also signiﬁcantly reduced in
PMNs from diabetic patients as compared to controls (Fig. 9C), this
potentially favoring enhanced S-glutathionylation in diabetes. To
validate these ﬁndings, migration of PMNs from diabetic patients
was compared with that of control neutrophils and found to be
signiﬁcantly reduced in the diabetic patients (Fig. 9D). PMN treat-
ment with DTT (1 mM for 10 min) partially reversed this inhibition.
Bactericidal activity of neutrophils was also signiﬁcantly reduced in
PMNs from diabetic patients as compared to controls (Fig. 9E).
Bacterial phagocytosis was also measured and marginally affected
in diabetic patients (Fig. S2F).
Chemotaxis, bactericidal activity, and LPL glutathionylation in db/db
mice
Enhanced LPL S-glutathionylation was also noted in the neu-
trophils obtained from db/db mice as compared to the wild-type
mice (Fig. 10A). ROS generation was also enhanced in the PMNs of
Fig. 6. Diamide-induced glutathionylation in wild-type (wt) and mutated LPLC460S (mut) overexpressed HEK293T cells. (A) Expression of wt LPL and mut LPLC460S in
HEK293T cells using anti-GFP antibody. (B) Histogram overlays show expression of wt LPL and mut LPLC460S in HEK293T cells. (C) Untransfected HEK293T or cells expressing
wt LPL or mut LPLC460S were treated with diamide (0.5 mM for 30 min). For cell invasion assay, HEK293T cells were seeded on Matrigel-coated polycarbonate ﬁlters. Invaded
cells were counted after 24 h. (D) Diamide-induced LPL S-glutathionylation in cells expressing wt LPL or mut LPLC460S. Data are shown as mean 7 SEM of three independent
experiments. ***Po0.001 vs control HEK293T cells, $$Po0.01 vs wt LPL overexpressed HEK293T cells, @Po0.05 vs diamide-treated wt LPL overexpressed HEK293T cells.
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db/db mice (Fig. 10B), while bacterial killing and migration in
response to fMLP were signiﬁcantly reduced (Fig. 10C, D, and E).
Discussion
Neutrophils are the most abundant and short-lived WBCs in
human blood and constitute the ﬁrst line of defense against invading
pathogens [42]. These cells generate the highest amount of ROS and
also play a vital role in inﬂammatory pathologies [43]. It is now well
accepted that resting as well as activated human PMNs generate NO,
though in lesser amounts as compared to mice PMNs [4]. Under
infectious or inﬂammatory conditions expression of iNOS is further
upregulated by LPS and/or inﬂammatory cytokines [44,45].
The migration of PMNs to the site of infection is crucial for the
effective resolution of infection [46]. Successful chemotaxis requires not
only increased motility but also sustained directionality. This study
demonstrates that exogenous treatment with NO reduced fMLP-
induced neutrophil chemotaxis independently of cGMP. Previously
reported increased chemotaxis of PMNs in iNOS–/– mice [47] was also
observed by us (Fig. 1E) and was further augmented by fMLP, thereby
underscoring the regulatory role of NO in PMN migration. The
concentration of NO during sepsis at inﬂammatory sites is believed to
be in the micromolar range. DETA-NO at the concentrations employed
in our study (100–300 mM) releases approximately 0.5–1.5 mM NO and
hence likely mimicking pathophysiological levels [48]. Treatment with
NO donor led to impaired chemotaxis, polarization, phagocytosis, and
ROS generation following phagocytosis. Even though NO-mediated
defective neutrophil migration has been reported in sepsis and other
pathologies, the molecular mechanisms involved have not been inves-
tigated in depth [49,50]. Cell polarization, an initial step for directional
migration, is partly accomplished through cell elongation. PDGF and
Rac-1-driven ﬁbroblast migration were reported as attenuated by NO
due to reduced ﬁlopodia formation [39]. In agreement with this we also
observed that NO affected PMN polarization. In the current study
phagocytosis and bactericidal activity in NO-pretreated human PMNs
were also attenuated (Fig. 2) but were prevented by DTT, suggesting the
role of redox regulation in NO-mediated responses. PMNs migrate to
the site of infection, phagocytose the invading pathogens, and subse-
quently kill them through oxidative and nonoxidative mechanisms
[3,5]. All these crucial steps required for the resolution of the infection
were found to be reduced to a variable extent in NO-pretreated PMNs.
On the other hand intracellular iNOS is critical for the bacterial killing
and NO production is enhanced during phagocytosis [4]. Enhanced ROS
production under basal conditions in neutrophils and reduced bacter-
icidal activity were observed in various pathological conditions [17].
Surprisingly we found that prior exposure to NO negatively regulated
chemotaxis, phagocytosis, and bacterial killing due to increased oxida-
tive stress and were prevented by DPI, VAS-2870, NAC, and DTT as well
as in PMNs from NCF-1–/– mice. NO-induced free radical generation in
PMNs is well established [40,51] and enhanced ROS leading to oxi-
dative modiﬁcations of proteins has also been reported in several
other cell types [52,53]. Peroxynitrite generated from NO and
O2– cause oxidation and nitration of susceptible molecules [54,55].
S-Glutathionylation is a functionally relevant redox-sensitive rever-
sible protein posttranslational modiﬁcation [56] and has also been
Fig. 7. Effect of NO-induced S-glutathionylation on F-actin content. (A) Confocal images showing phalloidin–TRITC (0.25 mM) labeling in control and DETA-NO (300 mM)-
treated human PMNs. (B) Bar diagram represents phalloidin–TRITC ﬂuorescence as analyzed by Image J software. (C) Fluorescence difference in the methanol-extracted
phalloidin–TRITC (0.25 mM) in the control and DETA-NO (300 mM)-treated cells. (D) The bars represent phalloidin–FITC ﬂuorescence in DETA-NO (300 mM)-treated cells at 30
min. (E) Histogram overlays show phalloidin–FITC ﬂuorescence in DETA-NO-treated cells at 30 min. Data are shown as mean 7 SEM of three to ﬁve independent
experiments. **Po0.01 vs control neutrophils.
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proposed as a signaling mechanism under both physiological and
pathological conditions [56]. Several proteins are S-nitrosylated during
exposure to NO [57,58]; however, such modiﬁcations are labile and
their stability is often affected by the presence of thiols, predominantly
by GSH (glutathione), which ﬁnally leads to protein S-glutathionylation
[26,59]. The current study demonstrated that in human PMNs, NO-
induced RONS generation led to enhanced protein S-glutathionylation.
Involvement of NADPH oxidase in S-glutathionylation was conﬁrmed
by reduced signal of the glutathionylation in PMNs from NCF1–/– mice
and by the NOX inhibitors VAS-2870 (Fig. 3E, S1C). A large number of
cytoskeleton proteins are in fact modiﬁed by S-glutathionylation, which
includes β-actin, myosin, proﬁlin, vimentin, spectrin, and tubulin [60].
We have now identiﬁed and established S-thiolation of two neutrophil
proteins β-actin and L-plastin, which are crucial for cytoskeleton
arrangements. In the case of LPL, we believe this is the ﬁrst description
of S- glutathionylation.
LPL, a member of the ﬁmbrin family of actin-binding proteins,
is a leukocyte-speciﬁc β-actin binding protein and is character-
ized by two actin-binding domains and a headpiece region
containing two EF hand-type calcium-binding domains [61].
Plastin-mediated bundling of actin ﬁlaments enables the main-
tenance of structures such as lamellipodia and ﬁlopodia [34]. LPL
controls polarization and migration of chemokine-stimulated T
lymphocytes [62]. Modulation of PMN functions by LPL was
conﬁrmed by knocking down LPL. LPL silencing reduced PMN
migration and bacterial killing in human PMNs, indicating the
signiﬁcance of LPL in PMN functions (Fig. 8). LPL undergoes
phosphorylation at the serine residue in the headpiece regi-
on [61,62], which regulates LPL function in leukocytes. LPL
phosphorylation was, however, not affected in NO-pretreated
cells as observed using the anti-pSer LPL antibody (Fig. S1F).
The current study thus demonstrates regulation of LPL by S-
glutathionylation leading to inhibiting the interaction with actin.
Interestingly, our observation is supported by the previously
reported inhibition of PMN function by LPL alkylation with
bromophenacyl bromide [63]. Even though in the current study,
the role of S-glutathionylation in the regulation of LPL activity
has been conﬁrmed by several approaches, we cannot completely
rule out the presence of S-nitrosylation.
Experiments using pure and nonphosphorylated LPL protein
following S-glutathionylation in vitro did not yield pronounced
effects on interaction and β-actin bundling. However, LPL S-
glutathionylation marginally reduced the interaction as well as
the bundling of β-actin (Fig. 5F, G). LPL contains a total of 10
cysteine residues, among which three were identiﬁed by the IAM
switch technique to be susceptible to oxidative posttranslational
modiﬁcations [64]. These residues are Cys-206, Cys-283, and Cys-
460, present in the actin-binding domain of LPL. Cys residues
surrounded by basic amino acids are more susceptible targets for
oxidation [21]. Although the crystal structure of human LPL
protein is not fully resolved, from the molecular modeling simula-
tions using a Swiss model via ExPASy web server (http://swissmo-
del.expasy.org/), we found that Cys-206, Cys-283, and Cys-460
were present at the surface of the β-actin binding domains and
were surrounded by basic amino acids (histidine, lysine, and
arginine). Mutation of the LPL Cys-460 to serine had no effect on
LPL functions in HEK293T cells but was resistant to diamide-
induced LPL glutathionylation and inhibition of cell invasion, thus
highlighting the importance of LPL Cys-460 in the redox regulation
of LPL functions.
Chen et al. showed that PMNs deﬁcient in L-plastin failed to kill
Staphylococcus aureus both in vitro and in vivo, and that this defect
Fig. 8. Effect of LPL silencing on PMN chemotaxis and bactericidal activity. (A) Representative images of fMLP (100 nM)-induced neutrophil migration in control and LPL-
silenced human PMNs. Scale bars: 100mm in the images. (B) The same data are represented as bar diagram. (C) Silencing of LPL in human PMNs leads to reduced bactericidal
activity. (D) Phalloidin–FITC ﬂuorescence in control and LPL-silenced human PMNs after NO treatment. (E) NO induced actin S-glutathionylation in control and LPL-silenced
PMNs. (F) LPL expression after silencing with LPL siRNA. Data represent mean 7 SEM of three to ﬁve independent experiments. *Po0.05 (Student's t test), ***Po0.001 vs
scrambled siRNA-transfected cells.
M. Dubey et al. / Free Radical Biology and Medicine 86 (2015) 1–15 11
arises from failure to mount an efﬁcient adhesion-dependent
respiratory burst [35]. In the current study PMNs treated with
DETA-NO for 15 and 30 min showed reduced actin interaction and
impaired bactericidal activity as compared to the control untreated
PMNs, thus corroborating the importance of LPL-actin interactions.
Phagocytosis-induced respiratory burst was also reduced in PMNs
pretreated with NO (Fig. 3C). Yan et al. had shown reduced
bactericidal activity and oxidative burst in Gsr (glutathione reduc-
tase)-deﬁcient mice [65]. Gsr is involved in the reduction of
glutathione disulﬁde to glutathione.
S-Glutathionylation has been encountered in association with a
wide range of diseases, including cancer, lung disease, cardiovascular
diseases, neurodegenerative diseases, and diabetes [56]. Diabetes melli-
tus is a disease characterized by increased superoxide generation and
enhanced oxidative stress, and neutrophil dysfunction is one of the
major causes of diabetic complications. Diabetic condition is also
associated with delayed wound healing and susceptibility to infections.
Park et al. observed more susceptibility to Staphylococcus aureus
infection in db/db mice due to defects in innate immunity [66]. Early
reports described that glutathione metabolism is impaired in erythro-
cytes from patients with diabetesmellitus [67] and reduced GSH as well
as augmented GSSG levels were also found [68,69]. Our study also
corroborated the higher oxidative stress in diabetic patients and db/db
mice as evidenced by enhanced DCF ﬂuorescence in resting neutrophils.
Reduced chemotaxis and enhanced LPL S-glutathionylation were also
observed in the PMNs from diabetic subjects. A decrease in neutrophil
migration in db/db mice was previously reported by Spiller et al. [70]
and is in agreement with our observation. This effect was attributed to
the reduced expression of CXCR2 and high levels of AGP (α1-acid
glycoprotein) [70,71]. The fact that DTT in our study partially reve-
rted the inhibition of migration suggests a potential role for S-gluta-
thionylation in this phenomenon. Glutaredoxins are thiol–disulﬁde
oxidoreductases that reduce protein disulﬁdes and a number of studies
indicate that human Grx1 catalyze the reduction of mixed disulﬁdes
[72]. The reduced level of Grx-1 in the PMNs from diabetic patients
further supports the presence of enhanced S-glutathionylation in
diabetes (Fig. 9C). Increased levels of LPL S-glutathionylation are
consistent with this scenario and emphasize the importance of LPL in
the regulation of PMN functions.
Altogether our ﬁndings support that enhanced LPL S-glutath-
ionylation and associated changes in the function of PMNs in db/db
mice and diabetic patients represent an important molecular and
regulatory mechanism to control PMN functions and may contribute
to explain defective PMN functions in various pathological conditions.
Fig. 9. Status of L-plastin S-glutathionylation in the PMNs from control and diabetic patients. (A) Densitometry analysis of LPL S-glutathionylation in neutrophils from
healthy controls and diabetic patients (n¼5). Treatment with DTT (10 mM for 10 min) reduced LPL glutathionylation signal. LPL was immunoprecipitated, resolved by 8%
SDS-PAGE, and blotted with anti-GSH antibody. The blot is representative from three different experiments. (B) ROS generation was measured by DCF-DA (10 mM) in healthy
and diabetic patients. *Po0.05 (Student's t test) vs control neutrophils. (C) Grx1 mRNA expression in control and diabetic patients. ***Po0.001 (Student's t test) vs control
neutrophils. (D) fMLP (100 nM)-induced neutrophil migration was assessed in control and diabetic patients using the Boyden chamber. Scale bars: 100mm in the images.
(E) Comparison of bactericidal activity in neutrophils from healthy control and diabetic patients. Cells (1 106 cells/ml) were incubated with E. coli (1:50), after cell lysis, the
supernatant was plated on agar plates, and the number of colonies were counted after 24 h. Data represent mean 7 SEM of three to ﬁve independent experiments. *Po0.05,
**Po0.01, ***Po0.001 vs control neutrophils, $Po0.05, $$Po0.01 vs diabetic patient neutrophils.
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